TWI
BIO icon

Thomas White International’s Bio-Rad Laboratories Class A BIO Stock Holding History

Thomas White International’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,625
Closed -$182K – 382
2013
Q2 		$182K Buy
+1,625
New +$191K 0.03% 213

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Thomas White International's BIO Position: Q3 2013 in Review

Thomas White International sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2013, closing a stake of 1,625 shares — an estimated $182K sold.

Thomas White International first reported a position in BIO in Q2 2013 and held it in 1 quarter. The position peaked at $182K in Q2 2013. 203 funds tracked by Wall St. Rank hold BIO as of Q3 2013.

  • Thomas White International reported no remaining Bio-Rad Laboratories Class A position as of Q3 2013 after selling out during the quarter.
  • Thomas White International sold 1,625 Bio-Rad Laboratories Class A shares in Q3 2013, an estimated $182K.
  • Thomas White International first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 1 quarter.
  • Thomas White International's Bio-Rad Laboratories Class A position peaked at $182K in Q2 2013.
  • 203 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2013.

Based on Thomas White International's 13F filing for Q3 2013, filed 6 Nov 2013.